Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|March 18, 2015
[Targeted molecular therapies (except immunotherapy)]Jennifer Roux, Cécile Pages, Céleste Lebbé
Clinical Nuclear Medicine|April 3, 2025
Rare Immuno-Induced Keratoacanthomas Showed on 18F-FDG PET/CT in a Metastatic Melanoma PatientNaia Oillarburu, Cécile Pages, Vincent Sibaud, et al.
Plos Pathogens|January 19, 2012
Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaStéphanie Dupuy, Marion Lambert, David Zucman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 20, 2024
The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanomaMargaux Vanbockstael, Guillaume Bataillon, Mathilde Morisseau, et al.
La Revue De Medecine Interne|November 23, 2024
[Atypical and/or systemic dermatologic disorders related to immune checkpoint inhibitors: A review]Valérian Rivet, Vincent Sibaud, Jérémie Dion, et al.
Anticancer Research|November 1, 2007
Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markersFrançois Bertucci, Cécile Pages, Pascal Finetti, et al.
Seminars in Arthritis and Rheumatism|April 26, 2017
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumabMarie-Léa Gauci, Barouyr Baroudjian, Pauline Laly, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanomaMargaux Vanbockstael, Guillaume Bataillon, Mathilde Morisseau, et al.
Cancers|June 2, 2021
Systemic Treatment Initiation in Classical and Endemic Kaposi's Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort StudyLina Benajiba, Jérôme Lambert, Roberta La Selva, et al.
Investigational New Drugs|November 4, 2024
Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trialMathilde Morisseau, Carlos Gomez-Roca, Marie Viala, et al.
Pageof 2